Our broad-based transaction experience extends across a range of situations, industries and enterprise values
Categories
Year
Type
Industry
Announced: May 10, 2022Value: $12.2 billionStatus: PendingExclusive financial advisor to Biohaven on its sale to Pfizer
Announced: February 1, 2022Value: $8 billionStatus: PendingExclusive investment banker to a group of ad hoc lenders throughout Intelsat's chapter 11 proceedings, including a refinancing of existing secured debt and DIP facilities
Announced: February 14, 2022Value: $5.9 billionStatus: PendingFinancial advisor to the Special Committee of Cornerstone's Board of Directors on the sale of shares to Clayton, Dubilier & Rice that CD&R did not already own
Announced: January 10, 2022Value: $4.1 billionStatus: PendingLead financial advisor to R1 on its acquisition of Cloudmed
Announced: February 10, 2022Value: £1.9 billionStatus: PendingFinancial advisor to Informa on the divestiture of its Pharma Intelligence business to Warburg Pincus
Announced: February 7, 2022Value: $593 millionStatus: PendingExclusive financial advisor to Resideo on its acquisition of First Alert, Inc. from Newell Brands Inc.
Announced: January 27, 2022Value: $305 millionStatus: PendingFinancial advisor to Oscar on its exploration of strategic financing alternatives and sole placement agent on a private placement of convertible senior notes led by Dragoneer Investment Group
Announced: April 20, 2022Value: $280 millionStatus: PendingExclusive financial advisor to PTC on its acquisition of Intland Software
Announced: April 19, 2022Value: $250 millionStatus: PendingExclusive financial advisor to Checkmate on its sale to Regeneron Pharmaceuticals
Announced: March 9, 2022Status: PendingExclusive financial advisor to Vauban on its purchase of equity in Paprec Group
Announced: February 24, 2022Status: ClosedExclusive financial advisor to Kimberly-Clark on its acquisition of a majority stake in Thinx, Inc.
Announced: February 18, 2022Status: PendingExclusive financial advisor to Recipharm on its acquisition of Vibalogics
Announced: February 18, 2022Status: PendingExclusive financial advisor to Recipharm on its acquisition of Arranta Bio
Announced: February 14, 2022Status: ClosedLead financial advisor to Resonant on its purchase by Murata Manufacturing Co., Ltd.
Announced: February 11, 2022Status: ClosedFinancial advisor to Ole Smoky on its sale to Apax Partners
Announced: February 9, 2022Status: PendingExclusive financial advisor to Thirty Madison on its merger with Nurx
Announced: February 7, 2022Status: PendingExclusive financial advisor to Jacobs on its acquisition of StreetLight Data, Inc.